Despite ongoing challenges posed by the COVID-19 pandemic, the University of Guelph community has raised more than $500,000 in this year’s United Way campaign. 

Three University of Guelph researchers have been awarded more than $1.4 million in project grant funding from the Canadian Institutes of Health Research (CIHR) for studies intended to address antimicrobial resistance and understand chronic pain.  

ALL exams scheduled for today will be rescheduled to Saturday, Dec. 17. On Saturday, each exam's timeslot and location remain as planned.

Updates and additional information including availability of on-campus dining and details about the University's planned reopening, will be available on the University news page: https://news.uoguelph.ca/. Please monitor the news page for updates.

A need for community drove Jennifer Geddes-McAlister to found a network for mothers in science. Here’s what she learnt.

When Terry Van Raay’s team set out to deprive developing zebrafish of their normal symbiotic bacteria, he wasn’t sure what they would find. As it turns out, these microorganisms are hugely important to normal brain cell development, or neurogenesis. READ MORE HERE

Immunization & Flu Shot Clinics, University of Guelph

Online pledge cards are available through the U of G United Way website. Individuals who complete an online pledge card are entered into weekly Incentive Prize Draws for prizes from campus and community partners.

U of G scientists have made a discovery that could reduce the spread of tumours by hindering a protein that binds cancer cells together and allows them to invade tissues. READ MORE HERE

Using custom-made “mini-brains” in the lab, a University of Guelph scientist aims to help thwart deadly, hard-to-treat brain tumours.  READ MORE HERE

Many of us know that cystic fibrosis is a genetic disorder characterized by enduring and debilitating lung infections. What may be less well-known is that the main pathogen involved in these lung infections is Pseudomonas aeruginosa, a bacteria capable of causing significant morbidity and mortality in people with cystic fibrosis.